Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAX
|
ENSG00000125952.14 | MYC associated factor X |
TFEB
|
ENSG00000112561.13 | transcription factor EB |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MAX | hg19_v2_chr14_-_65569244_65569413 | 0.51 | 3.1e-03 | Click! |
TFEB | hg19_v2_chr6_-_41703296_41703367 | 0.36 | 4.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_58146128 | 3.66 |
ENST00000551800.1
ENST00000549606.1 ENST00000257904.6 |
CDK4
|
cyclin-dependent kinase 4 |
chr17_-_7137582 | 3.61 |
ENST00000575756.1
ENST00000575458.1 |
DVL2
|
dishevelled segment polarity protein 2 |
chr17_-_7137857 | 3.47 |
ENST00000005340.5
|
DVL2
|
dishevelled segment polarity protein 2 |
chr12_-_58146048 | 3.37 |
ENST00000547281.1
ENST00000546489.1 ENST00000552388.1 ENST00000540325.1 ENST00000312990.6 |
CDK4
|
cyclin-dependent kinase 4 |
chr14_-_94443105 | 2.60 |
ENST00000555019.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr19_+_5681153 | 2.54 |
ENST00000579559.1
ENST00000577222.1 |
HSD11B1L
RPL36
|
hydroxysteroid (11-beta) dehydrogenase 1-like ribosomal protein L36 |
chr16_+_2570431 | 2.48 |
ENST00000563556.1
|
AMDHD2
|
amidohydrolase domain containing 2 |
chr14_-_94443065 | 2.42 |
ENST00000555287.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr6_+_138188351 | 2.35 |
ENST00000421450.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr6_+_160390102 | 2.34 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
chr8_+_142402089 | 2.13 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
chr14_-_64761078 | 2.08 |
ENST00000341099.4
ENST00000556275.1 ENST00000542956.1 ENST00000353772.3 ENST00000357782.2 ENST00000267525.6 |
ESR2
|
estrogen receptor 2 (ER beta) |
chr5_+_133706865 | 2.07 |
ENST00000265339.2
|
UBE2B
|
ubiquitin-conjugating enzyme E2B |
chr6_+_138188378 | 1.93 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr15_+_41913690 | 1.89 |
ENST00000563576.1
|
MGA
|
MGA, MAX dimerization protein |
chr11_-_113746277 | 1.84 |
ENST00000003302.4
ENST00000545540.1 |
USP28
|
ubiquitin specific peptidase 28 |
chr1_-_11866034 | 1.75 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr8_+_11561660 | 1.66 |
ENST00000526716.1
ENST00000335135.4 ENST00000528027.1 |
GATA4
|
GATA binding protein 4 |
chr17_-_46688334 | 1.64 |
ENST00000239165.7
|
HOXB7
|
homeobox B7 |
chr1_-_171621815 | 1.64 |
ENST00000037502.6
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response |
chr12_-_65153175 | 1.59 |
ENST00000543646.1
ENST00000542058.1 ENST00000258145.3 |
GNS
|
glucosamine (N-acetyl)-6-sulfatase |
chr9_+_131709966 | 1.57 |
ENST00000372577.2
|
NUP188
|
nucleoporin 188kDa |
chr5_-_172198190 | 1.54 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr19_+_10764937 | 1.53 |
ENST00000449870.1
ENST00000318511.3 ENST00000420083.1 |
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
chr18_-_46987000 | 1.53 |
ENST00000442713.2
ENST00000269445.6 |
DYM
|
dymeclin |
chr11_-_113746212 | 1.52 |
ENST00000537642.1
ENST00000537706.1 ENST00000544750.1 ENST00000260188.5 ENST00000540925.1 |
USP28
|
ubiquitin specific peptidase 28 |
chr19_-_47734448 | 1.52 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
chr3_+_50654821 | 1.51 |
ENST00000457064.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
chr6_-_84937314 | 1.45 |
ENST00000257766.4
ENST00000403245.3 |
KIAA1009
|
KIAA1009 |
chr20_-_44519839 | 1.45 |
ENST00000372518.4
|
NEURL2
|
neuralized E3 ubiquitin protein ligase 2 |
chr12_-_66275350 | 1.44 |
ENST00000536648.1
|
RP11-366L20.2
|
Uncharacterized protein |
chr10_+_51827648 | 1.44 |
ENST00000351071.6
ENST00000314664.7 ENST00000282633.5 |
FAM21A
|
family with sequence similarity 21, member A |
chr19_+_10765003 | 1.44 |
ENST00000407004.3
ENST00000589998.1 ENST00000589600.1 |
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
chr1_+_17248418 | 1.43 |
ENST00000375541.5
|
CROCC
|
ciliary rootlet coiled-coil, rootletin |
chr6_+_7107830 | 1.43 |
ENST00000379933.3
|
RREB1
|
ras responsive element binding protein 1 |
chr8_-_124553437 | 1.40 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr7_-_27196267 | 1.39 |
ENST00000242159.3
|
HOXA7
|
homeobox A7 |
chr2_+_46926048 | 1.37 |
ENST00000306503.5
|
SOCS5
|
suppressor of cytokine signaling 5 |
chr2_+_176987088 | 1.37 |
ENST00000249499.6
|
HOXD9
|
homeobox D9 |
chr3_+_50654550 | 1.37 |
ENST00000430409.1
ENST00000357955.2 |
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
chr19_+_8386371 | 1.36 |
ENST00000600659.2
|
RPS28
|
ribosomal protein S28 |
chr5_+_148786518 | 1.34 |
ENST00000518014.1
ENST00000505340.1 ENST00000509909.1 |
AC131025.8
MIR143HG
|
AC131025.8 MIR143 host gene (non-protein coding) |
chr1_+_221051699 | 1.33 |
ENST00000366903.6
|
HLX
|
H2.0-like homeobox |
chr16_+_2570340 | 1.32 |
ENST00000568263.1
ENST00000293971.6 ENST00000302956.4 ENST00000413459.3 ENST00000566706.1 ENST00000569879.1 |
AMDHD2
|
amidohydrolase domain containing 2 |
chr9_-_34048873 | 1.30 |
ENST00000449054.1
ENST00000379239.4 ENST00000539807.1 ENST00000379238.1 ENST00000418786.2 ENST00000360802.1 ENST00000412543.1 |
UBAP2
|
ubiquitin associated protein 2 |
chr4_-_2935674 | 1.29 |
ENST00000514800.1
|
MFSD10
|
major facilitator superfamily domain containing 10 |
chr16_-_28503357 | 1.28 |
ENST00000333496.9
ENST00000561505.1 ENST00000567963.1 ENST00000354630.5 ENST00000355477.5 ENST00000357076.5 ENST00000565688.1 ENST00000359984.7 |
CLN3
|
ceroid-lipofuscinosis, neuronal 3 |
chr17_-_46667594 | 1.28 |
ENST00000476342.1
ENST00000460160.1 ENST00000472863.1 |
HOXB3
|
homeobox B3 |
chr19_-_40854281 | 1.27 |
ENST00000392035.2
|
C19orf47
|
chromosome 19 open reading frame 47 |
chr2_-_220042825 | 1.23 |
ENST00000409789.1
|
CNPPD1
|
cyclin Pas1/PHO80 domain containing 1 |
chr12_-_53625958 | 1.22 |
ENST00000327550.3
ENST00000546717.1 ENST00000425354.2 ENST00000394426.1 |
RARG
|
retinoic acid receptor, gamma |
chr5_+_148786423 | 1.22 |
ENST00000505254.2
ENST00000602964.1 ENST00000519898.1 |
MIR143HG
|
MIR143 host gene (non-protein coding) |
chr17_+_72270429 | 1.22 |
ENST00000311014.6
|
DNAI2
|
dynein, axonemal, intermediate chain 2 |
chr11_-_1912084 | 1.22 |
ENST00000391480.1
|
C11orf89
|
chromosome 11 open reading frame 89 |
chr13_-_21635631 | 1.22 |
ENST00000382592.4
|
LATS2
|
large tumor suppressor kinase 2 |
chr19_-_49137762 | 1.21 |
ENST00000593500.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr3_+_127317705 | 1.19 |
ENST00000480910.1
|
MCM2
|
minichromosome maintenance complex component 2 |
chr17_-_39093672 | 1.18 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
chrY_+_15016013 | 1.18 |
ENST00000360160.4
ENST00000454054.1 |
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr19_-_40324767 | 1.18 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
chr5_+_133707252 | 1.17 |
ENST00000506787.1
ENST00000507277.1 |
UBE2B
|
ubiquitin-conjugating enzyme E2B |
chr16_+_4897632 | 1.17 |
ENST00000262376.6
|
UBN1
|
ubinuclein 1 |
chr19_-_40854417 | 1.17 |
ENST00000582006.1
ENST00000582783.1 |
C19orf47
|
chromosome 19 open reading frame 47 |
chr7_-_27179814 | 1.17 |
ENST00000522788.1
ENST00000521779.1 |
HOXA3
|
homeobox A3 |
chr12_+_54393880 | 1.16 |
ENST00000303450.4
|
HOXC9
|
homeobox C9 |
chr17_+_33474826 | 1.16 |
ENST00000268876.5
ENST00000433649.1 ENST00000378449.1 |
UNC45B
|
unc-45 homolog B (C. elegans) |
chr7_-_27205136 | 1.15 |
ENST00000396345.1
ENST00000343483.6 |
HOXA9
|
homeobox A9 |
chr6_+_138188551 | 1.15 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr2_-_227664474 | 1.15 |
ENST00000305123.5
|
IRS1
|
insulin receptor substrate 1 |
chr17_+_72270380 | 1.14 |
ENST00000582036.1
ENST00000307504.5 |
DNAI2
|
dynein, axonemal, intermediate chain 2 |
chrX_+_16804544 | 1.14 |
ENST00000380122.5
ENST00000398155.4 |
TXLNG
|
taxilin gamma |
chrY_-_15591485 | 1.14 |
ENST00000382896.4
ENST00000537580.1 ENST00000540140.1 ENST00000545955.1 ENST00000538878.1 |
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
chr1_+_32712815 | 1.13 |
ENST00000373582.3
|
FAM167B
|
family with sequence similarity 167, member B |
chr4_-_100242549 | 1.12 |
ENST00000305046.8
ENST00000394887.3 |
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide |
chr19_+_45504688 | 1.12 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
chr6_+_7108210 | 1.12 |
ENST00000467782.1
ENST00000334984.6 ENST00000349384.6 |
RREB1
|
ras responsive element binding protein 1 |
chr13_+_113951607 | 1.10 |
ENST00000397181.3
|
LAMP1
|
lysosomal-associated membrane protein 1 |
chr2_+_46926326 | 1.10 |
ENST00000394861.2
|
SOCS5
|
suppressor of cytokine signaling 5 |
chr12_+_54426637 | 1.09 |
ENST00000312492.2
|
HOXC5
|
homeobox C5 |
chr16_-_28503080 | 1.09 |
ENST00000565316.1
ENST00000565778.1 ENST00000357857.9 ENST00000568558.1 ENST00000357806.7 |
CLN3
|
ceroid-lipofuscinosis, neuronal 3 |
chr11_-_61684962 | 1.08 |
ENST00000394836.2
|
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
chr2_+_239047337 | 1.08 |
ENST00000409223.1
ENST00000305959.4 |
KLHL30
|
kelch-like family member 30 |
chrX_+_153627231 | 1.07 |
ENST00000406022.2
|
RPL10
|
ribosomal protein L10 |
chr19_-_12886327 | 1.07 |
ENST00000397668.3
ENST00000587178.1 ENST00000264827.5 |
HOOK2
|
hook microtubule-tethering protein 2 |
chr5_+_65440032 | 1.06 |
ENST00000334121.6
|
SREK1
|
splicing regulatory glutamine/lysine-rich protein 1 |
chr9_-_127269661 | 1.06 |
ENST00000373588.4
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
chrX_+_95939638 | 1.06 |
ENST00000373061.3
ENST00000373054.4 ENST00000355827.4 |
DIAPH2
|
diaphanous-related formin 2 |
chr1_-_53608249 | 1.06 |
ENST00000371494.4
|
SLC1A7
|
solute carrier family 1 (glutamate transporter), member 7 |
chr10_-_120514720 | 1.05 |
ENST00000369151.3
ENST00000340214.4 |
CACUL1
|
CDK2-associated, cullin domain 1 |
chr17_+_33474860 | 1.04 |
ENST00000394570.2
|
UNC45B
|
unc-45 homolog B (C. elegans) |
chr14_-_106668095 | 1.04 |
ENST00000390606.2
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
chr7_-_27135591 | 1.03 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
chr8_-_82395461 | 1.03 |
ENST00000256104.4
|
FABP4
|
fatty acid binding protein 4, adipocyte |
chr11_-_64014379 | 1.02 |
ENST00000309318.3
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr2_-_197036289 | 1.02 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
chr14_-_65569244 | 1.01 |
ENST00000557277.1
ENST00000556892.1 |
MAX
|
MYC associated factor X |
chr18_+_3247413 | 1.01 |
ENST00000579226.1
ENST00000217652.3 |
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
chr15_-_82555000 | 1.00 |
ENST00000557844.1
ENST00000359445.3 ENST00000268206.7 |
EFTUD1
|
elongation factor Tu GTP binding domain containing 1 |
chr2_-_47572207 | 1.00 |
ENST00000441997.1
|
AC073283.4
|
AC073283.4 |
chr17_-_46667628 | 1.00 |
ENST00000498678.1
|
HOXB3
|
homeobox B3 |
chr16_+_28986134 | 0.99 |
ENST00000352260.7
|
SPNS1
|
spinster homolog 1 (Drosophila) |
chr17_+_40440481 | 0.98 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
chr2_+_177025619 | 0.97 |
ENST00000410016.1
|
HOXD3
|
homeobox D3 |
chr3_+_132757215 | 0.97 |
ENST00000321871.6
ENST00000393130.3 ENST00000514894.1 ENST00000512662.1 |
TMEM108
|
transmembrane protein 108 |
chr16_+_68119247 | 0.97 |
ENST00000575270.1
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
chr1_-_39325431 | 0.97 |
ENST00000373001.3
|
RRAGC
|
Ras-related GTP binding C |
chr12_+_54366894 | 0.97 |
ENST00000546378.1
ENST00000243082.4 |
HOXC11
|
homeobox C11 |
chr6_-_144329531 | 0.96 |
ENST00000429150.1
ENST00000392309.1 ENST00000416623.1 ENST00000392307.1 |
PLAGL1
|
pleiomorphic adenoma gene-like 1 |
chrX_+_131157609 | 0.96 |
ENST00000496850.1
|
MST4
|
Serine/threonine-protein kinase MST4 |
chr10_-_46089939 | 0.95 |
ENST00000453980.3
|
MARCH8
|
membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase |
chr17_-_7218403 | 0.95 |
ENST00000570780.1
|
GPS2
|
G protein pathway suppressor 2 |
chr6_+_7107999 | 0.95 |
ENST00000491191.1
ENST00000379938.2 ENST00000471433.1 |
RREB1
|
ras responsive element binding protein 1 |
chr15_-_50978965 | 0.94 |
ENST00000560955.1
ENST00000313478.7 |
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7 |
chr1_+_22778337 | 0.94 |
ENST00000404138.1
ENST00000400239.2 ENST00000375647.4 ENST00000374651.4 |
ZBTB40
|
zinc finger and BTB domain containing 40 |
chr19_+_49990811 | 0.94 |
ENST00000391857.4
ENST00000467825.2 |
RPL13A
|
ribosomal protein L13a |
chr12_+_54378923 | 0.93 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
chr1_-_11865982 | 0.93 |
ENST00000418034.1
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr1_-_226129083 | 0.93 |
ENST00000420304.2
|
LEFTY2
|
left-right determination factor 2 |
chr7_-_27183263 | 0.93 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr6_-_109703600 | 0.93 |
ENST00000512821.1
|
CD164
|
CD164 molecule, sialomucin |
chr14_-_65569057 | 0.92 |
ENST00000555419.1
ENST00000341653.2 |
MAX
|
MYC associated factor X |
chr19_-_49137790 | 0.92 |
ENST00000599385.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr3_-_113465065 | 0.92 |
ENST00000497255.1
ENST00000478020.1 ENST00000240922.3 ENST00000493900.1 |
NAA50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
chr2_-_98612379 | 0.92 |
ENST00000425805.2
|
TMEM131
|
transmembrane protein 131 |
chr11_+_112038088 | 0.92 |
ENST00000530752.1
ENST00000280358.4 |
TEX12
|
testis expressed 12 |
chr3_+_133292851 | 0.91 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
chr12_+_14518598 | 0.91 |
ENST00000261168.4
ENST00000538511.1 ENST00000545723.1 ENST00000543189.1 ENST00000536444.1 |
ATF7IP
|
activating transcription factor 7 interacting protein |
chr11_+_101981423 | 0.91 |
ENST00000531439.1
|
YAP1
|
Yes-associated protein 1 |
chr7_+_73868220 | 0.91 |
ENST00000455841.2
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
chr19_+_14544099 | 0.91 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
chr11_-_3663480 | 0.90 |
ENST00000397068.3
|
ART5
|
ADP-ribosyltransferase 5 |
chr10_+_69644404 | 0.90 |
ENST00000212015.6
|
SIRT1
|
sirtuin 1 |
chr6_-_109703663 | 0.90 |
ENST00000368961.5
|
CD164
|
CD164 molecule, sialomucin |
chr2_+_238395879 | 0.89 |
ENST00000445024.2
ENST00000338530.4 ENST00000409373.1 |
MLPH
|
melanophilin |
chr3_+_133292759 | 0.89 |
ENST00000431519.2
|
CDV3
|
CDV3 homolog (mouse) |
chr11_-_3663502 | 0.89 |
ENST00000359918.4
|
ART5
|
ADP-ribosyltransferase 5 |
chr4_-_100871506 | 0.89 |
ENST00000296417.5
|
H2AFZ
|
H2A histone family, member Z |
chr17_+_38474489 | 0.89 |
ENST00000394089.2
ENST00000425707.3 |
RARA
|
retinoic acid receptor, alpha |
chr11_+_63706444 | 0.89 |
ENST00000377793.4
ENST00000456907.2 ENST00000539656.1 |
NAA40
|
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
chr12_+_53399942 | 0.89 |
ENST00000262056.9
|
EIF4B
|
eukaryotic translation initiation factor 4B |
chr11_+_67776012 | 0.88 |
ENST00000539229.1
|
ALDH3B1
|
aldehyde dehydrogenase 3 family, member B1 |
chr6_-_144329384 | 0.87 |
ENST00000417959.2
|
PLAGL1
|
pleiomorphic adenoma gene-like 1 |
chr10_-_97175444 | 0.86 |
ENST00000486141.2
|
SORBS1
|
sorbin and SH3 domain containing 1 |
chr3_+_188889737 | 0.86 |
ENST00000345063.3
|
TPRG1
|
tumor protein p63 regulated 1 |
chr16_-_28503327 | 0.86 |
ENST00000535392.1
ENST00000395653.4 |
CLN3
|
ceroid-lipofuscinosis, neuronal 3 |
chr18_+_3247779 | 0.86 |
ENST00000578611.1
ENST00000583449.1 |
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
chr12_+_53400176 | 0.86 |
ENST00000551002.1
ENST00000420463.3 ENST00000416762.3 ENST00000549481.1 ENST00000552490.1 |
EIF4B
|
eukaryotic translation initiation factor 4B |
chr11_-_126081532 | 0.85 |
ENST00000533628.1
ENST00000298317.4 ENST00000532674.1 |
RPUSD4
|
RNA pseudouridylate synthase domain containing 4 |
chr16_+_28986085 | 0.85 |
ENST00000565975.1
ENST00000311008.11 ENST00000323081.8 ENST00000334536.8 |
SPNS1
|
spinster homolog 1 (Drosophila) |
chr14_-_65569186 | 0.85 |
ENST00000555932.1
ENST00000358664.4 ENST00000284165.6 ENST00000358402.4 ENST00000246163.2 ENST00000556979.1 ENST00000555667.1 ENST00000557746.1 ENST00000556443.1 |
MAX
|
MYC associated factor X |
chr20_+_44519948 | 0.84 |
ENST00000354880.5
ENST00000191018.5 |
CTSA
|
cathepsin A |
chr1_-_3447967 | 0.84 |
ENST00000294599.4
|
MEGF6
|
multiple EGF-like-domains 6 |
chr11_+_9595180 | 0.84 |
ENST00000450114.2
|
WEE1
|
WEE1 G2 checkpoint kinase |
chr10_-_3827371 | 0.83 |
ENST00000469435.1
|
KLF6
|
Kruppel-like factor 6 |
chr3_+_184032419 | 0.82 |
ENST00000352767.3
ENST00000427141.2 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
chr19_+_49458107 | 0.82 |
ENST00000539787.1
ENST00000345358.7 ENST00000391871.3 ENST00000415969.2 ENST00000354470.3 ENST00000506183.1 ENST00000293288.8 |
BAX
|
BCL2-associated X protein |
chrY_-_15591818 | 0.82 |
ENST00000382893.1
|
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
chr4_-_100575781 | 0.81 |
ENST00000511828.1
|
RP11-766F14.2
|
Protein LOC285556 |
chr9_-_19127474 | 0.81 |
ENST00000380465.3
ENST00000380464.3 ENST00000411567.1 ENST00000276914.2 |
PLIN2
|
perilipin 2 |
chr10_+_46222648 | 0.81 |
ENST00000336378.4
ENST00000540872.1 ENST00000537517.1 ENST00000374362.2 ENST00000359860.4 ENST00000420848.1 |
FAM21C
|
family with sequence similarity 21, member C |
chrX_+_95939711 | 0.81 |
ENST00000373049.4
ENST00000324765.8 |
DIAPH2
|
diaphanous-related formin 2 |
chr14_+_61789382 | 0.81 |
ENST00000555082.1
|
PRKCH
|
protein kinase C, eta |
chr10_+_99258625 | 0.81 |
ENST00000370664.3
|
UBTD1
|
ubiquitin domain containing 1 |
chr10_+_23728198 | 0.80 |
ENST00000376495.3
|
OTUD1
|
OTU domain containing 1 |
chr21_-_38445470 | 0.80 |
ENST00000399098.1
|
PIGP
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr19_-_36545128 | 0.79 |
ENST00000538849.1
|
THAP8
|
THAP domain containing 8 |
chr20_+_44520009 | 0.79 |
ENST00000607482.1
ENST00000372459.2 |
CTSA
|
cathepsin A |
chr7_+_2393714 | 0.79 |
ENST00000431643.1
|
EIF3B
|
eukaryotic translation initiation factor 3, subunit B |
chr10_-_31320840 | 0.79 |
ENST00000375311.1
|
ZNF438
|
zinc finger protein 438 |
chr1_+_110009150 | 0.78 |
ENST00000401021.3
|
SYPL2
|
synaptophysin-like 2 |
chr12_-_110434096 | 0.78 |
ENST00000320063.9
ENST00000457474.2 ENST00000547815.1 ENST00000361006.5 |
GIT2
|
G protein-coupled receptor kinase interacting ArfGAP 2 |
chr15_+_82555125 | 0.78 |
ENST00000566205.1
ENST00000339465.5 ENST00000569120.1 ENST00000566861.1 |
FAM154B
|
family with sequence similarity 154, member B |
chr12_-_110434021 | 0.77 |
ENST00000355312.3
ENST00000551209.1 ENST00000550186.1 |
GIT2
|
G protein-coupled receptor kinase interacting ArfGAP 2 |
chr18_+_56530794 | 0.77 |
ENST00000590285.1
ENST00000586085.1 ENST00000589288.1 |
ZNF532
|
zinc finger protein 532 |
chr4_-_47465666 | 0.77 |
ENST00000381571.4
|
COMMD8
|
COMM domain containing 8 |
chr2_-_20251744 | 0.77 |
ENST00000175091.4
|
LAPTM4A
|
lysosomal protein transmembrane 4 alpha |
chr2_+_10183651 | 0.77 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
chr14_-_93799360 | 0.77 |
ENST00000334746.5
ENST00000554565.1 ENST00000298896.3 |
BTBD7
|
BTB (POZ) domain containing 7 |
chr9_-_110251836 | 0.77 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr1_+_43148625 | 0.77 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
chr19_-_47290535 | 0.76 |
ENST00000412532.2
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
chr19_+_50016610 | 0.76 |
ENST00000596975.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr3_-_196065374 | 0.76 |
ENST00000454715.1
|
TM4SF19
|
transmembrane 4 L six family member 19 |
chr12_+_54674482 | 0.75 |
ENST00000547708.1
ENST00000340913.6 ENST00000551702.1 ENST00000330752.8 ENST00000547276.1 |
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1 |
chr17_+_5185552 | 0.75 |
ENST00000262477.6
ENST00000408982.2 ENST00000575991.1 ENST00000537505.1 ENST00000546142.2 |
RABEP1
|
rabaptin, RAB GTPase binding effector protein 1 |
chr22_-_50700140 | 0.75 |
ENST00000215659.8
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr5_+_78532003 | 0.75 |
ENST00000396137.4
|
JMY
|
junction mediating and regulatory protein, p53 cofactor |
chr18_-_3247084 | 0.75 |
ENST00000609924.1
|
RP13-270P17.3
|
RP13-270P17.3 |
chr10_+_112327425 | 0.75 |
ENST00000361804.4
|
SMC3
|
structural maintenance of chromosomes 3 |
chr5_-_158636512 | 0.74 |
ENST00000424310.2
|
RNF145
|
ring finger protein 145 |
chr3_-_195163584 | 0.74 |
ENST00000439666.1
|
ACAP2
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 |
chr9_-_35650900 | 0.73 |
ENST00000259608.3
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1 |
chr5_-_121413974 | 0.73 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
chr1_+_52521797 | 0.73 |
ENST00000313334.8
|
BTF3L4
|
basic transcription factor 3-like 4 |
chr17_-_7218631 | 0.73 |
ENST00000577040.2
ENST00000389167.5 ENST00000391950.3 |
GPS2
|
G protein pathway suppressor 2 |
chr4_+_76439095 | 0.72 |
ENST00000506261.1
|
THAP6
|
THAP domain containing 6 |
chr17_+_37356586 | 0.72 |
ENST00000579260.1
ENST00000582193.1 |
RPL19
|
ribosomal protein L19 |
chr19_-_36545649 | 0.72 |
ENST00000292894.1
|
THAP8
|
THAP domain containing 8 |
chr2_+_176981307 | 0.72 |
ENST00000249501.4
|
HOXD10
|
homeobox D10 |
chr12_+_122516626 | 0.72 |
ENST00000319080.7
|
MLXIP
|
MLX interacting protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0072573 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
1.8 | 7.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.9 | 3.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.8 | 3.2 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.8 | 3.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.7 | 5.9 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.6 | 1.8 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.5 | 1.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 2.7 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.5 | 3.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.3 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.4 | 1.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.4 | 3.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 1.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 2.0 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 4.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 1.2 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.4 | 1.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.4 | 1.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 1.4 | GO:1903566 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 1.8 | GO:0007538 | primary sex determination(GO:0007538) |
0.3 | 0.7 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.3 | 1.0 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.3 | 0.9 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.3 | 0.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.3 | 0.9 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 1.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 0.8 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.3 | 1.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.3 | 0.8 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.3 | 2.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.8 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.2 | 1.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 2.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 1.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
0.2 | 0.7 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.2 | 0.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.7 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.2 | 2.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 1.9 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.2 | 0.8 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.2 | 0.8 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 0.6 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.2 | 0.5 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.2 | 0.5 | GO:0002368 | B cell cytokine production(GO:0002368) protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 2.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 0.5 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.2 | 0.9 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.5 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 1.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 0.5 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.2 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.3 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 0.6 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.2 | 0.5 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.2 | 2.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 2.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.4 | GO:1990828 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.1 | 0.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 2.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.6 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.1 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 2.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 1.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 1.2 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.1 | 1.0 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 0.4 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.1 | 1.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 1.2 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 0.5 | GO:0009386 | translational attenuation(GO:0009386) |
0.1 | 0.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.1 | 2.5 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 1.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.4 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.1 | 1.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.6 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.1 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.9 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.3 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 1.4 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.6 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 1.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.2 | GO:1902903 | regulation of fibril organization(GO:1902903) |
0.1 | 0.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.1 | 0.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 2.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 1.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.3 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.1 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 14.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 1.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.3 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.4 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.3 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.1 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 1.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 2.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 1.4 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 1.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.4 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.2 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.1 | 1.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.8 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.2 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.1 | 2.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 2.1 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.3 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 0.3 | GO:0090402 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) oncogene-induced cell senescence(GO:0090402) positive regulation of cellular response to X-ray(GO:2000685) |
0.1 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.5 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 1.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.6 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 1.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.2 | GO:0035606 | induction of programmed cell death(GO:0012502) peptidyl-cysteine S-trans-nitrosylation(GO:0035606) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 0.3 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.1 | 0.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.1 | 1.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 1.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.3 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.5 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.4 | GO:2000909 | endosome localization(GO:0032439) regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.2 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.1 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.1 | 0.1 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.1 | 0.4 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 1.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 1.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 6.6 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 1.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.7 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.1 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.1 | 0.2 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.1 | 0.2 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.1 | 1.5 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.3 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 0.6 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.2 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 1.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.1 | 0.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.2 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 3.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 0.6 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.2 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.1 | 0.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.7 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.3 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 1.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.3 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0018016 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.8 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.9 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 1.3 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
0.0 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 2.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 3.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 2.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.2 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 1.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 2.2 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 3.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.3 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.0 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 1.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.5 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.3 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.0 | 0.1 | GO:1905133 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
0.0 | 2.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.0 | 1.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.9 | GO:0006068 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
0.0 | 0.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) establishment of viral latency(GO:0019043) |
0.0 | 1.2 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.3 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.7 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 1.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.0 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 1.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.3 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.1 | GO:0072387 | flavin-containing compound biosynthetic process(GO:0042727) flavin adenine dinucleotide metabolic process(GO:0072387) |
0.0 | 0.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 1.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 1.4 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 1.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.8 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.2 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.0 | 0.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.0 | 2.7 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 1.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.6 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.9 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 0.5 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.9 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.0 | 0.1 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.2 | GO:1990403 | protein localization to ciliary transition zone(GO:1904491) embryonic brain development(GO:1990403) |
0.0 | 2.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 2.5 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 1.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 2.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 1.5 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.6 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.5 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.0 | 0.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.5 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.2 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.6 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 1.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.0 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) negative regulation of macrophage activation(GO:0043031) |
0.0 | 1.3 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.3 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 1.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 1.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 1.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.9 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 1.5 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.6 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.4 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 5.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.2 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.1 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.4 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.0 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.5 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.1 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 5.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.5 | 4.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 2.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 1.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 0.3 | GO:0035101 | FACT complex(GO:0035101) |
0.3 | 1.9 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 3.2 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.5 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 2.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.6 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.2 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.8 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.2 | 2.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 2.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 1.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 2.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 7.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 3.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 1.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.9 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 1.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.9 | GO:0000801 | central element(GO:0000801) |
0.1 | 6.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 7.0 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 2.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.4 | GO:0002133 | polycystin complex(GO:0002133) |
0.1 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.6 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 8.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 1.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.8 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 1.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 1.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 1.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 1.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 8.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 1.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 1.4 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 3.8 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 4.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 4.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 2.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.0 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 3.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 1.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 19.0 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.0 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.0 | 0.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 1.7 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 8.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.6 | 1.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.6 | 2.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 2.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.5 | 2.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.5 | 1.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 1.7 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.4 | 2.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 1.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.3 | 1.0 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.3 | 1.8 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 0.9 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 5.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.3 | 1.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.8 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.2 | 2.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 2.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.2 | 1.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.9 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.2 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 9.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 1.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.9 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.2 | 1.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 1.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.4 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 1.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 0.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 1.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 1.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.6 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 0.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 5.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.6 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.1 | 2.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 2.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 2.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.1 | 0.4 | GO:0030305 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
0.1 | 0.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.1 | 1.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 2.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 1.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 2.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.2 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.5 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 3.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.8 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.7 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 1.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.3 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.1 | 0.2 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 2.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 2.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 1.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 3.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.7 | GO:0070290 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.1 | 0.3 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.1 | 0.5 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 7.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 1.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 13.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 2.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 1.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 4.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 3.7 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 1.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.0 | 0.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 2.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 2.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 1.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.7 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 3.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 3.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 4.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.0 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 1.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 1.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 2.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.0 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.2 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 19.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 0.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 1.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.0 | 1.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 1.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 1.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 1.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0050473 | prostaglandin-endoperoxide synthase activity(GO:0004666) arachidonate 15-lipoxygenase activity(GO:0050473) |
0.0 | 0.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 1.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.3 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.0 | 0.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 1.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 2.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 1.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 8.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 1.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 1.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 1.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 6.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 6.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 4.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.9 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.3 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 2.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 3.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 4.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 3.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 3.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 2.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 2.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 3.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 3.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 2.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 2.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 3.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 9.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 3.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 11.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 9.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 5.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 5.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 5.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 6.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 1.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 1.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 3.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 3.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 6.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 2.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 2.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 2.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 4.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |